H-1 NMR spectroscopy was used to study the oligonucleotide binding of
the a enantiomers of [Ru(phen)(2)L](2+) where the bidentate ligand L i
s 1,10-phenanthroline (phen), dipyrido[3,2-d:2',3'-f]quinoxaline (dpq)
or yrido-[3,2-a:2',3'-c](6,7,8,9-tetrahydro)phenazine (dpqC). The dat
a from one- and two-dimensional NMR experiments of the oligonucleotide
-metal complex binding suggest that all three ruthenium(II) polypyridy
l complexes bind in the DNA minor groove. While a minimally intercalat
ed oligonucleotide binding mode may be proposed for Delta-[Ru(phen)(3)
](2+), the NMR data clearly indicate that Delta-[Ru(phen)(2)dpq](2+) b
inds the hexanucleotide d(GTCGAC)(2) by intercalation, of the dpq liga
nd, from the minor groove. This demonstrates that metallointercalators
can intercalate from the DNA minor groove. Molecular modeling of the
metal complex in the intercalation site suggests that Delta-[Ru(phen)(
2)dpq](2+) binds in a ''head-on'' fashion with the phenanthroline ring
s in the minor groove and the dpq ligand inserted into the nucleotide
base stack. NOESY experiments of the binding of Delta-[Ru(phen)(2)dpq]
(2+) with d(GTCGAC)(2) and d(TCGGGATCCCGA)(2) suggest that intercalati
on from the minor groove is favored at purine-purine/pyrimidine-pyrimi
dine sequences for this complex. The syntheses of Delta-[Ru(phen)(2)dp
q](2+) and Delta-[Ru(phen)(2)dpqC](2+) are reported along with crystal
structure of [Ru(phen)(2)dpq](PF6)(2) (monoclinic crystal system, spa
ce group P2(1)/c, Z = 4, a = 9.483(2) Angstrom, b = 33.374(6) Angstrom
, c = 12.900(3) Angstrom, beta = 110.05(2)degrees, V= 3835(2) Angstrom
(3)).